What is the intrinsic value of NUS?
As of 2025-09-18, the Intrinsic Value of NU Skin Enterprises Inc (NUS) is
10.18 USD. This NUS valuation is based on the model Peter Lynch Fair Value.
With the current market price of 11.86 USD, the upside of NU Skin Enterprises Inc is
-14.12%.
Is NUS undervalued or overvalued?
Based on its market price of 11.86 USD and our intrinsic valuation, NU Skin Enterprises Inc (NUS) is overvalued by 14.12%.
10.18 USD
Intrinsic Value
NUS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(176.57) - (11.42) |
(20.50) |
-272.8% |
| DCF (Growth 10y) |
(3.84) - (23.88) |
(5.00) |
-142.1% |
| DCF (EBITDA 5y) |
(2.49) - (2.64) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(1.01) - 0.08 |
(1,234.50) |
-123450.0% |
| Fair Value |
10.18 - 10.18 |
10.18 |
-14.12% |
| P/E |
25.05 - 42.04 |
35.39 |
198.4% |
| EV/EBITDA |
11.43 - 16.60 |
13.96 |
17.7% |
| EPV |
22.86 - 32.54 |
27.70 |
133.6% |
| DDM - Stable |
28.99 - 200.21 |
114.60 |
866.2% |
| DDM - Multi |
(15.58) - (82.27) |
(26.05) |
-319.7% |
NUS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
587.07 |
| Beta |
1.21 |
| Outstanding shares (mil) |
49.50 |
| Enterprise Value (mil) |
571.81 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.85% |
| Cost of Debt |
7.21% |
| WACC |
6.21% |